Tuesday, May 22, 2018 4:47:41 PM
483,000,000 Authorized Common / 7,000,000 Authorized Series “A”
Preferred
71,857,024 Outstanding Common / 0 Outstanding Preferred
Of Which:
45,103,024 are restricted
26,754,000 are unrestricted
—————————————————-
= 71,857,024
Buyer receives a control block of:
200,000,000 shares restricted
200,000,000 CONTROL BLOCK
+71,857,024
—————————————————-
= 271,857,024 TOTAL OUTSTANDING WITH THE BLOCK
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM